CAS: 2443767-35-7
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | BPR1K871 REF: IN-DA01TP4JCAS: 2443767-35-7 | 98% | A consultar | Mar 07 Ene 25 |
 | BPR1K871 REF: TM-T10592CAS: 2443767-35-7 | - - - | 1.161,00 €~1.994,00 € | Mar 07 Ene 25 |
 | BPR1K871 REF: 3D-TXD76735CAS: 2443767-35-7 | Min. 95% | A consultar | Mar 18 Feb 25 |
Ref: IN-DA01TP4J
| 1mg | A consultar | ||
| 5mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 7 de Enero de 2025
BPR1K871
CAS:2443767-35-7
BPR1K871, a preclinical development candidate for anti-cancer therapy [1], is a potent, selective dual inhibitor …
Fórmula:
C25H28ClN7O2S
Forma y color:
Solid
Peso molecular:
526.05
Ref: TM-T10592
| 10mg | 1.161,00 € | ||
| 25mg | 1.994,00 € |
Entrega estimada en Estados Unidos, el Martes 7 de Enero de 2025
BPR1K871
CAS:2443767-35-7
BPR1K871 is a synthetic, orally bioavailable anticancer compound that has potent anticancer activity. It is …
Fórmula:
C25H28ClN7O2S
Pureza:
Min. 95%
Peso molecular:
526.1 g/mol
Ref: 3D-TXD76735
| 1mg | A consultar | ||
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 18 de Febrero de 2025
